Kinase Inhibitors and Ovarian Cancer

Kinase Inhibitors and Ovarian Cancer

Ovarian cancer is fifth in the rankings of cancer deaths among women, and accounts for more deaths than any other gynecological malignancy. Despite some improvement in overall-(OS) and progression-free survival (PFS) following surgery and first-line chemotherapy, there is a need for development of n...

Full description

Bibliographic Details
Main Authors: Periklis Katopodis, Dimple Chudasama, Gurleen Wander, Louise Sales, Juhi Kumar, Manreen Pandhal, Vladimir Anikin, Jayanta Chatterjee, Marcia Hall, Emmanouil Karteris
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Cancers
Subjects:
kinase inhibitors
rapalogs
ovarian cancer
mTOR
TKI
Online Access:https://www.mdpi.com/2072-6694/11/9/1357

Similar Items

Similar Items